The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak spreads in dairy cows.

The U.S. government is reportedly close to finalizing a deal with Moderna to fund its bird flu mRNA vaccine trial as concerns remain surrounding the outbreak in poultry and cattle. The Financial ...

Moderna announced on Tuesday a deal with the US government to fund a late-stage trial of its pandemic bird flu vaccine. The announcement comes after months of speculation surrounding the Cambridge ...

In its own announcement on Tuesday, Moderna noted that it began a Phase 1/2 trial of a pandemic influenza virus vaccine last year, which included versions targeting H5 and H7 varieties of bird flu ...

The government has 4.8 million doses of an H5 vaccine with a traditional platform under production, O’Connell said. The vaccine is tailored to the currently circulating strains of the H5N1 bird ...

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as it works to develop its product portfolio while cutting costs.

Moderna Inc. is close to clinching a deal with the US Department of Defense to develop messenger RNA vaccines targeting a range of biological threats such as Ebola virus.